GlassScriptPhysician profile
Jerry W Miller
NPI 1811936511
$8,367.46
in general payments reported to CMS, 2019-2025
35 companies · $664 in 2025
The $664 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,511 · 2020: $793 · 2021: $1,539 · 2022: $1,233 · 2023: $1,674 · 2024: $954 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,291.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,938.08 | 2021-2025 | Endurant Iis, Symplicity G3, Onyx Frontier |
| Astrazeneca Pharmaceuticals LP | $1,908.63 | 2019-2025 | Farxiga, Andexxa, Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $802.44 | 2019-2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $726.06 | 2019-2023 | |
| Amgen INC. | $371.95 | 2019-2023 | Repatha |
| Heartflow, INC. | $246.41 | 2022-2023 | Ffrct |
| Sanofi-Aventis U.S. LLC | $223.68 | 2019 | |
| Biotronik INC. | $219.72 | 2021-2022 | |
| Abiomed | $198.11 | 2023-2024 | Impella |
| Janssen Pharmaceuticals, INC | $180.83 | 2020-2024 | Xarelto |
| Inari Medical, INC. | $173.04 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merck Sharp & Dohme LLC | $149.37 | 2021-2025 | Verquvo |
| Impulse Dynamics (USA) INC. | $147.08 | 2023 | Optimizer |
| Abbott Laboratories | $138.13 | 2024 | Diamondback Coronary |
| Medtronic Vascular, INC. | $133.91 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $105.13 | 2020-2022 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $101.87 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $76.42 | 2019-2023 | Camzyos |
| Edwards Lifesciences Corporation | $67.97 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $58.30 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $54.51 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.53 | 2021-2022 | |
| Novo Nordisk INC | $40.02 | 2023-2025 | Wegovy, Ozempic |
| Medline Industries LP | $37.10 | 2023 | |
| Pfizer INC. | $34.03 | 2020-2022 | |
| Philips North America LLC | $27.80 | 2021 | |
| Scpharmaceuticals INC. | $24.40 | 2024 | |
| Boston Scientific Corporation | $22.12 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.49 | 2021 | |
| Stryker Corporation | $17.36 | 2025 | Artix Mt |
| Biocompatibles, INC. | $16.54 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $15.79 | 2019 | |
| Amarin Pharma, INC. | $15.28 | 2019 | |
| Alfasigma USA, INC. | $14.48 | 2020 | |
| Arbor Pharmaceuticals, INC. | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.